Top
AHSG has not been detected as a mutational cancer driver

AHSG
Ensembl id ENSG00000145192
Mutated samples
Coding Sequence 41 (0.6%)
Protein Affecting 29 (0.4%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all AHSG gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 10 8 2.17
Lung adenocarcinoma No 8 4 1.02
Lung squamous cell carcinoma No 4 3 1.72
Bladder carcinoma No 2 2 2.04
Uterine corpus endometrioid carcinoma No 2 2 0.87
Non small cell lung carcinoma No 2 2 6.45
Small cell lung carcinoma No 2 2 2.90
Head and neck squamous cell carcinoma No 2 2 0.53
Prostate adenocarcinoma No 1 1 0.41
Medulloblastoma No 1 1 0.48
Stomach adenocarcinoma No 2 1 0.62
Esophageal carcinoma No 1 1 0.68
Hepatocarcinoma No 1 0 0.00
Renal clear cell carcinoma No 1 0 0.00
Thyroid carcinoma No 1 0 0.00
Pylocytic astrocytoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence